REVIEW
Published on 24 Jan 2024
Clinical research on RSV prevention in children and pregnant women: progress and perspectives
doi 10.3389/fimmu.2023.1329426
- 7,995 views
- 11 citations
- Frontiers in Immunology
- Vaccines and Molecular Therapeutics
- Research Topics
- Overcoming Challenges in Vaccines and Molecular Therapeutics: 2022
Overcoming Challenges in Vaccines and Molecular Therapeutics: 2022
22k
Total downloads
85k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 08 Dec 2023
Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern
doi 10.3389/fimmu.2023.1307693
- 2,698 views
- 6 citations
REVIEW
Published on 27 Nov 2023
Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines
doi 10.3389/fimmu.2023.1294288
- 5,589 views
- 8 citations
REVIEW
Published on 03 Nov 2023
Side effects of COVID-19 vaccines in the middle eastern population
doi 10.3389/fimmu.2023.1270187
- 8,330 views
- 1 citation
ORIGINAL RESEARCH
Published on 05 Oct 2023
Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer
doi 10.3389/fimmu.2023.1260195
- 2,866 views
- 11 citations
CLINICAL TRIAL
Published on 18 Sep 2023
Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial
doi 10.3389/fimmu.2023.1241153
- 1,847 views
- 4 citations
ORIGINAL RESEARCH
Published on 02 Jun 2023
Increasing human monoclonal antibody cloning efficiency with a whole-cell modified immunoglobulin-capture assay (mICA)
doi 10.3389/fimmu.2023.1184510
- 3,570 views
REVIEW
Published on 02 Jun 2023
Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
doi 10.3389/fimmu.2023.1200195
- 26,395 views
- 60 citations
ORIGINAL RESEARCH
Published on 19 May 2023
A tetravalent nanoparticle vaccine elicits a balanced and potent immune response against dengue viruses without inducing antibody-dependent enhancement
doi 10.3389/fimmu.2023.1193175
- 5,230 views
- 12 citations
HYPOTHESIS AND THEORY
Published on 26 Apr 2023
Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
doi 10.3389/fimmu.2023.1183258
- 4,170 views
- 13 citations
ORIGINAL RESEARCH
Published on 21 Apr 2023
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
doi 10.3389/fimmu.2023.1182963
- 4,448 views
- 9 citations
ORIGINAL RESEARCH
Published on 20 Mar 2023
Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants
doi 10.3389/fimmu.2023.1154496
- 2,397 views
- 7 citations
